Financials data is unavailable for this security.
View more
Year on year Shenzhen Lifotronic Technology Co Ltd grew revenues 16.55% from 983.04m to 1.15bn while net income improved 30.66% from 251.48m to 328.58m.
| Gross margin | 67.06% |
|---|---|
| Net profit margin | 31.79% |
| Operating margin | 34.01% |
| Return on assets | 15.37% |
|---|---|
| Return on equity | 21.26% |
| Return on investment | 21.09% |
More ▼
Cash flow in CNYView more
In 2023, Shenzhen Lifotronic Technology Co Ltd increased its cash reserves by 56.66%, or 352.15m. The company earned 303.82m from its operations for a Cash Flow Margin of 26.52%. In addition the company generated 103.12m cash from financing while 59.97m was spent on investing.
| Cash flow per share | -- |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | 4.55 |
|---|---|
| Tangible book value per share | 4.19 |
More ▼
Balance sheet in CNYView more
| Current ratio | 2.44 |
|---|---|
| Quick ratio | 2.25 |
| Total debt/total equity | 0.3216 |
|---|---|
| Total debt/total capital | 0.2434 |
More ▼
Growth rates in CNY
Year on year, both dividends per share and earnings per share excluding extraordinary items growth increased 18.57% and 29.27%, respectively. The positive trend in dividend payments is noteworthy since very few companies in the Medical Equipment & Supplies industry pay a dividend. Additionally, five year annualized earnings per share growth ranks above the industry average relative to its peers.
| Div yield(5 year avg) | 0.99% |
|---|---|
| Div growth rate (5 year) | -- |
| Payout ratio (TTM) | 31.57% |
| EPS growth(5 years) | 29.19 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | 25.14 |
More ▼
